Evidence map›Paper›PMID 40522391›Full record

ArticleBreast cancer research and treatment2025

Promoting resilience in stress management (PRISM) for patients with early stage breast cancer: a pilot feasibility study.

Gabrielle B Rocque, Etzael Ortiz Olguin, Jessi M Shuey, Tanvi Padalkar, Courtney P Williams, Andres Azuero, Ana Falcao, Nicole L Henderson, Chloe J Taub, Molly Ream and 4 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Breast cancer research and treatment, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Gabrielle B RocqueDepartment of Medicine, Division of Hematology Oncology, University of Alabama at Birmingham, 1808 7 Th Avenue S, Birmingham, AL, 35233, USA. grocque@uabmc.edu.ORCID http://orcid.org/0000-0003-4188-9785
Etzael Ortiz OlguinDepartment of Medicine, Division of Hematology Oncology, University of Alabama at Birmingham, 1808 7 Th Avenue S, Birmingham, AL, 35233, USA.ORCID http://orcid.org/0009-0009-9617-9036
Jessi M ShueyDepartment of Medicine, Division of Hematology Oncology, University of Alabama at Birmingham, 1808 7 Th Avenue S, Birmingham, AL, 35233, USA.
Tanvi PadalkarDepartment of Medicine, Division of Hematology Oncology, University of Alabama at Birmingham, 1808 7 Th Avenue S, Birmingham, AL, 35233, USA.
Courtney P WilliamsO'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, USA.ORCID http://orcid.org/0000-0001-5328-7517
Andres AzueroO'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, USA.ORCID http://orcid.org/0000-0001-9883-1424
Ana FalcaoDepartment of Medicine, Division of Hematology Oncology, University of Alabama at Birmingham, 1808 7 Th Avenue S, Birmingham, AL, 35233, USA.
Nicole L HendersonDepartment of Medicine, Division of Hematology Oncology, University of Alabama at Birmingham, 1808 7 Th Avenue S, Birmingham, AL, 35233, USA.ORCID http://orcid.org/0000-0003-2101-3065
Chloe J TaubDepartment of Medicine, Division of General Internal Medicine and Population Science, University of Alabama at Birmingham, Birmingham, AL, USA.ORCID http://orcid.org/0000-0001-5467-9758
Molly ReamDepartment of Supportive Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.ORCID http://orcid.org/0000-0002-6400-9739
Joyce P Yi-FrazierDepartment of Supportive Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.ORCID http://orcid.org/0000-0002-7057-7249
Courtney C JunkinsDepartment of Supportive Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.ORCID http://orcid.org/0009-0002-3651-1040
Katherine Reeder-HayesDepartment of Medicine, Division of Oncology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.ORCID http://orcid.org/0000-0001-6903-0177
Abby R RosenbergDepartment of Supportive Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.ORCID http://orcid.org/0000-0002-7608-607X

Funding

American Cancer Society TheoryLab Collaborative TLC-23-1180714-01-TLCDaiichi Sankyo, INC 86931821
6 · The paper itself

Abstract

purposeWomen with breast cancer often experience persistent psychological distress. Promoting resilience in stress management (PRISM) is a manualized, skills-based, psychosocial intervention shown to promote resilience and alleviate psychological distress among adolescents and young adults with cancer.

methodsThis pilot, convergent mixed methods study examined PRISM's feasibility and in-sample preliminary impact (single-group) on psychosocial outcomes of women with early stage breast cancer (EBC). Women receiving chemotherapy for stage I-III breast cancer completed six standard PRISM sessions focused on rapport building, stress management, goal setting, cognitive reframing, meaning-making, and family integration. Feasibility, the primary outcome, was defined as 70% of participants completing all intervention sessions and pre-post survey. Secondary outcomes included intervention acceptability, appropriateness, and 8 psychosocial outcomes. Patient perspectives on PRISM were elucidated via qualitative interviews and deductively analyze. Pre- and post-intervention changes in survey scores were analyzed using paired t-tests and Cohen's d effect size.

resultsOf 57 patients approached, 30 (53%) participated in PRISM; participants were 57% Black with median age of 51 years (IQR 47-59). PRISM sessions were feasible based on the 83% completion rate. Additional secondary implementation outcomes also demonstrated feasibility, acceptability, and appropriateness using validated survey measured. The largest effects were observed in participants' resilience (d = 0.6), growth (d = 0.5), and self-improvement (d = 0.5). Interviews supported both feasibility and impact of PRISM.

conclusionThe PRISM-EBC intervention was feasible, and pre-post changes suggest potential benefit, warranting further investigation in a future randomized controlled trial.

Indexed as

Breast NeoplasmsResilience, PsychologicalStress, PsychologicalAdultFeasibility StudiesFemaleHumansMiddle AgedNeoplasm StagingPilot ProjectsPsychological DistressBreast cancerFeasibilityPilot studyResilience

Identifiers

PMID40522391
PMCPMC12209016

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.